Skip to main content
Elsevier
View Cart
Your Account

Journals in Cancer

BooksJournals

Cancer Pathogenesis and Therapy

  • ISSN: 2949-7132
Cancer Pathogenesis and Therapy (CPT) is an international open access journal covering key topics in all aspects of cancer research, focusing on mechanism innovation, emerging interdisciplinary and clinical trials research in Oncology. As a Chinese Medical Association (CMA) journal, it strives to publish the highest quality content that provides authoritative guidance to oncology specialists, physicians and researchers.CPT is dedicated to publishing innovative and significant research results in basic research, translation research and clinical oncology, including novel antitumor drugs, especially clinical trials, early screening/prevention, precise diagnosis and targeted therapy, interdisciplinary oncology innovation research and clinical translation in genetics, bioinformatics, pharmacology, and biology, and also new viewpoints, new ideas, new methods and new models of cancer prevention and public health policy.CPT regularly features news and expert interviews to promote expert oncologists' views on oncology guidelines, consensus , and education.CPT is concerned about, but not limited to, the following academic scopes: Basic Cancer Research, Clinical Cancer Research, Cancer prevention and public health policy, Oncological Pharmacology, Cancer Genomics, Cancer Informatics, Drug discovery, Artificial Intelligence, etc.The article types for CPT include: Research articles, Review article, Evidence-based Oncology, Clinical Trial, Editorial, Guideline and Consensus, Study Protocols, Mini review, Perspective, Case report, technical notes, Clinical Image, Letter to Editor, etc.P-ISSN 2097-2563
Subscribe

Cell Insight

  • ISSN: 2772-8927
Cell Insight is an international, peer-reviewed open-access journal that publishes cutting-edge research articles, letters and reviews on biomedical sciences. The mission of Cell Insight is to provide a fast and expert peer review process to authors and to accelerate communications of researchers for their discoveries in the biological and biomedical fields. The primary criterion for considering manuscripts is whether the studies provide advances into answering important questions relevant to biological and biomedical sciences.Research areas include but are not limited to:Cell biologyImmunologyMicrobiologyCancer biologyNeuroscienceGeneticsMetabolismDisease mechanismsNew technology related to biomedical researchTranslational researchCell Insight is published by Elsevier in partnership with Wuhan University, one of the most comprehensive research universities in China. Led by a team of distinguished scientists, Cell Insight creates a platform of a professional review process and a fast publication process with high quality standards to accelerate scientific communications.
Subscribe

Cell Reports Medicine

  • ISSN: 2666-3791
  • Impact factor: 11.7
Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.Visit the Cell Press website for more information about Cell Reports Medicine - http://www.cell.com/cell-reports-medicine/home
Subscribe

Clinical and Translational Radiation Oncology

  • ISSN: 2405-6308
  • 5 Year impact factor: 3.3
  • Impact factor: 2.7
An Official Journal of The European Society for Radiotherapy and OncologyClinical and Translational Radiation Oncology is an international, open access journal which encompasses all aspects of clinical and translational radiation oncology research, particularly new developments in experimental radiobiology, clinical interventions and treatments. This includes imaging and biomarker studies with clinical endpoints, as well as research results from data sciences, epidemiology, and oncopolicy.The journal publishes original research articles, review articles, short communications, technical notes, case series and reports, and correspondence.For any information regarding Clinical and Translational Radiation Oncology please contact [email protected].
Subscribe

Current Problems in Cancer: Case Reports

  • ISSN: 2666-6219
  • 5 Year impact factor: 0.2
  • Impact factor: 0.2
Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer. Our topics are comprehensive, encompassing new understandings of cancer diagnosis, tumor biology, and treatment decisions. We also welcome tumor board reports which showcase multidisciplinary discussions of illustrative cases within a defined tumor group.A companion title to Current Problems in Cancer, the Journal provides a global forum for clinicians and researchers to share their personal experiences through case reports. We hope that academic and community physicians, providers, and students will participate and learn from this collection of case reports.
Subscribe

ESMO Gastrointestinal Oncology

  • ISSN: 2949-8198
ESMO Gastrointestinal Oncology is the European Society for Medical Oncology's latest peer-reviewed open access journal, dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.The journal aims to publish experimental, translational, diagnostic and therapeutic research. Specific areas of interest include but are not limited to gastrointestinal cancer biology and epidemiology, prevention and early detection, advances in molecular, genetic and imaging diagnostics, therapeutic studies from pre-clinical to clinical (phase I-IV) with a focus on targeted and immunotherapy, translational research, patient-oriented studies, psychosocial aspects of disease, treatment of long-term morbidity and survivorship, palliative and supportive care, novel methods and clinical protocols. The journal welcomes original articles, reviews, mini reviews, editorials, research methods and clinical trial summaries, and correspondence. In addition, it provides in-depth commentaries from leading experts and engages in active debate on important topics via its pro and con discussion section.ESMO Gastrointestinal Oncology is committed to providing swift review and publication supported by our team of experienced international experts and key opinion leaders. The journal will provide essential reading for cancer researchers, clinician-scientists, clinicians with a focus gastrointestinal cancer, patient advocates and all health care professionals with a specific interest in gastrointestinal cancers. The journal rapidly disseminates the best innovative clinical and translational research and aims to improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.
Subscribe

ESMO Real World Data and Digital Oncology

  • ISSN: 2949-8201
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology's latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand.The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational and health services research, clinical informatics solutions, algorithm-powered diagnostics, and decision support systems and direct-to-patient mobile applications.Main focuses of interest include: disease characterization, rare and under-represented populations in clinical trials, head-to-head comparative effectiveness, unmet needs and gaps in access or care delivery, resource utilization and heath economics, post-marketing treatment optimization and tolerability and patients' outcomes and preferences. In addition, studies that evaluate the net benefit of incorporating artificial intelligence applications in clinical practice, or explore how the human aspect of medicine, relations between patient and physician, may be affected by the increasing use of technology in routine practice.With an international editorial board of experts and key opinion leaders, the journal will support multiple stakeholders as they engage with digital solutions and information systems to solve complex cancer problems. Providing essential reading for all stakeholders we will publish original research, reviews, editorials, perspectives, correspondence, and news.The journal will provide balanced implementation guidance, training, and resources to ensure appropriate use of real-world data and digital technologies, at the highest methodological standards.ESMO Real-World Data and Digital Oncology aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process.
Subscribe

HPB

  • ISSN: 1365-182X
  • 5 Year impact factor: 3.2
  • Impact factor: 2.7
To visit the HPB journal website click here: http://www.hpbonline.org/HPB is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.Abstracted and Indexed in:MEDLINE®EMBASEPubMedScience Citation Index ExpandedAcademic Search (EBSCO)HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
Subscribe

Heliyon

  • ISSN: 2405-8440
  • 5 Year impact factor: 3.9
  • Impact factor: 3.4
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.
Subscribe

Innovative Practice in Breast Health

  • ISSN: 2950-2128
The aim of Innovative Practice in Breast-Health is to provide a platform for the sharing of new knowledge and research related to evaluation of applications of new technologies in the field of breast diseases. The journal seeks to promote the development and understanding of the latest advances in artificial intelligence, data science and data omics, telemedicine, image-assisted surgery, connected objects and telemedicine, prediction, personalized medicine and simulation in the field of breast cancer and other breast pathologies.This journal will publish high quality peer-reviewed original research, review articles, editorials, case reports (proof of concept of innovative applications of artificial intelligence-related technologies), and perspectives that encompass the evaluation and application of innovative technologies in the treatment, prevention, diagnosis and management of breast pathologies.Innovative Practice in Breast-Health welcomes research from all relevant disciplines, provided that it involves artificial intelligence-related technologies and breast diseases, including but not limited to surgery, imaging, medical oncology, radiation oncology, pathology, genetics, epidemiology, public health, nursing and allied health sciences, psychology, sociology, education, economic and health policy and management.The scope of the journal includes but is not limited to:Clinical trials and translational research regarding artificial intelligence-related technologies and breast pathologiesArtificial intelligence and its application to data science, data omics, telemedicine and breast pathologiesAlgorithms for analyzing large-scale data sets for breast cancer diagnosis, prognosis and treatment; and also patient experience and patient-related outcomesMachine learning and deep learning approaches for breast imaging and surgeryTelemedicine and telehealth applications for the management and screening of breast cancer and breast diseasesBig data and data omics applications in breast cancer research, diagnosis and treatment
Subscribe